Document Detail

Rapid loading of intravenous lacosamide: Efficacy and practicability during presurgical video-EEG monitoring.
MedLine Citation:
PMID:  22998639     Owner:  NLM     Status:  Publisher    
Purpose:  This study investigates immediate efficacy and safety of intravenous application of de novo lacosamide (LCM) as add-on therapy in patients with pharmacoresistant focal epilepsy. Methods:  During presurgical video-electroencephalography (EEG) monitoring, 17 adult inpatients received LCM infusion (200 mg every 12 h for 2-3 days) followed by oral formulation with the same regimen. Before and after intravenous application of LCM, seizures and interictal epileptiform discharges (IEDs) recorded with continuous video-EEG monitoring were analyzed, and an assessment of adverse events (AEs) was performed daily. To evaluate the midterm tolerability and efficacy, follow-up visits were conducted 1 and 3 months after discharge from hospital. Key Findings:  In the acute phase, intravenous initiation of LCM was well tolerated with few mild or moderate AEs (3 of 17, 17.6%). A significant reduction of seizure frequency in the treatment phase as compared to mean seizure frequency in the 2-day baseline phase was achieved (p < 0.05 for the first treatment day, and p < 0.005 for the second treatment day). On the first treatment day, 61.5% of the patients were seizure free, and 84.6% on the second treatment day. IED reduction after intravenous application of LCM was not significant. After 1 month, the 50% responder rate was 46.6% and after the 3-month period, 42.8%. Significance:  Our data suggest that rapid intravenous initiation of de novo LCM is safe and may protect against seizures in a rapid and midterm time window.
Wenjie Li; Hermann Stefan; Julia Matzen; Stefan Rampp; Hans-Joachim Heinze; Friedhelm C Schmitt
Related Documents :
24929679 - Intermittent clobazam prophylaxis in hot water epilepsy is safe and effective: a prospe...
1479389 - Anticoagulant treatment as a risk factor for primary intracerebral haemorrhage.
16133889 - Low-molecular-weight-heparins as periprocedural anticoagulation for patients on long-te...
9627139 - Has hospital mortality from acute myocardial infarction been markedly reduced since the...
16784079 - Prevention of thrombosis and embolism in children and adolescents with mechanical valve...
24655479 - Observational dutch young symptomatic stroke study (odyssey): study rationale and proto...
23849079 - Use of antivenoms for the treatment of envenomation by elapidae snakes in guinea, sub-s...
25368909 - Evaluation of transverse maxillary expansion after a segmental posterior subapical maxi...
17413469 - Surgical strategy for cervical myelopathy due to ossification of the posterior longitud...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-9-21
Journal Detail:
Title:  Epilepsia     Volume:  -     ISSN:  1528-1167     ISO Abbreviation:  Epilepsia     Publication Date:  2012 Sep 
Date Detail:
Created Date:  2012-9-24     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  2983306R     Medline TA:  Epilepsia     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
© 2012 International League Against Epilepsy.
Department of Neurology, University of Magdeburg, Magdeburg, Germany Neurological Clinic, University Hospital Erlangen, Erlangen, Germany.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Roles of Proteins, Polysaccharides and Phenolics on Haze Formation in White Wine via Reconstitution ...
Next Document:  Novel treatment avenues for peripheral T-cell lymphomas.